Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Masaoki, Harada"'
Autor:
Takanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, Masaru Wakatsuki, Noriyuki Okonogi, Masaoki Harada, Tomohiko Ichikawa, Koichiro Akakura, Yoshitaka Murakami, Hiroshi Tsuji, Shigeru Yamada
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 8815-8825 (2023)
The aim of this retrospective study was to identify clinical predictors of early biochemical recurrence (BCR) in patients with high-risk prostate cancer (PCa) treated with carbon-ion radiotherapy (CIRT) and androgen deprivation therapy (ADT). A total
Externí odkaz:
https://doaj.org/article/3df2bf2286d148739fc44fc044fc1fd1
Autor:
Akira Yokomizo, Hirofumi Koga, Kazuto Ito, Yutaka Takezawa, Motokiyo Komiyama, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Naoya Masumori, Gaku Arai, Shiro Saito, Mitsuru Shinohara, Nobuaki Shimizu, Atsushi Yamauchi, Takefumi Satoh, Tatsuo Tochigi, Mikio Kobayashi, Hiroyuki Fujimoto, Ken‐ichi Kakimoto, Iwao Fukui, Taiji Tsukamoto, Miwako Nozaki, Katsuyuki Karasawa, Masaru Hasumi, Mikinobu Ohtani, Hiromichi Ishiyama, Masaaki Kuwahara, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake, Tadao Kakizoe, Kazuhiro Suzuki, Seiji Naito, Hidetoshi Yamanaka, National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3240-3248 (2021)
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for pati
Externí odkaz:
https://doaj.org/article/4fc6d5a819fc4ff3b13b667c17fde309
Autor:
Takanobu Utsumi, Hiroyoshi Suzuki, Hitoshi Ishikawa, Yuichi Hiroshima, Masaru Wakatsuki, Masaoki Harada, Tomohiko Ichikawa, Koichiro Akakura, Hiroshi Tsuji
Publikováno v:
Japanese Journal of Clinical Oncology. 52:950-953
The aim of this study was to reclassify high-risk prostate cancer patients treated with carbon-ion radiotherapy and androgen deprivation therapy using the Candiolo nomogram and evaluate usefulness to predict the following 10-year biochemical recurren
Autor:
Tatsuo Tochigi, Ken-Ichi Kakimoto, Taiji Tsukamoto, Tadao Kakizoe, Iwao Fukui, Yasuo Ohashi, Gaku Arai, Masaru Hasumi, Nobuaki Shimizu, Mitsuru Shinohara, Yutaka Takezawa, Kazuo Nishimura, Mikio Kobayashi, Mikinobu Ohtani, Hidetoshi Yamanaka, Hiromichi Ishiyama, Toshihiko Kotake, Shiro Saito, Naoya Masumori, Seiji Naito, Motokiyo Komiyama, Katsuyoshi Hashine, Kazuto Ito, Hiroyuki Fujimoto, Katsuyuki Karasawa, Takefumi Satoh, Masaaki Kuwahara, Miwako Nozaki, Masaoki Harada, Kazuhiro Suzuki, Junji Yonese, Atsushi Yamauchi, Akira Yokomizo
Publikováno v:
CancerReferences. 126(17)
Background To date, research has not determined the optimal procedure for adjuvant androgen deprivation therapy (ADT) in patients with locally advanced prostate cancer (PCa) treated for 6 months with neoadjuvant ADT and external-beam radiation therap
Autor:
Yoshinobu Kubota, Yasuhiro Shibata, Naoya Masumori, Hiroji Uemura, Kazuhiro Suzuki, Masataka Taguri, Yasuhide Miyoshi, Norio Nonomura, Yoshiki Sugimura, Masaoki Harada, Seijiro Honma, Susumu Umemoto, Tomohiko Ichikawa, Atsushi Mizokami, Kentaro Sakamaki, Hideki Sakai
Publikováno v:
The Prostate. 76:376-382
BACKGROUND There is no consensus on blood adrenal androgen concentrations in men with different stages and pathological grades of prostate cancer. In this study, dehydroepiandrosterone (DHEA) concentrations in blood were examined by ultrasensitive li
Autor:
Yoshinobu Kubota, Yasuhide Miyoshi, Seijiro Homma, Masaoki Harada, Hiroji Uemura, Kazuhiro Suzuki, Yutaro Hayashi, Yasuhiro Shibata
Publikováno v:
Journal of Urology. 197
Autor:
Jun Shimazaki, Tohru Okada, Koichiro Akakura, Masaoki Harada, Hitoshi Ishikawa, Tadashi Kamada, Hiroyoshi Suzuki, Hiroshi Tsuji, Tomohiko Ichikawa, Hirohiko Tsujii
Publikováno v:
Japanese Journal of Clinical Oncology. 44:360-365
Background: A novel risk assessment method, Japan Cancer of the Prostate Risk Assessment, has been developed based on database of patients receiving primary androgen deprivation therapy. To investigate the usefulness of Japan Cancer of the Prostate R
Autor:
Kiyoshi Fujinami, Takeshi Sasaki, Yoshiyasu Nakamura, Masaoki Harada, Yoichi Kameda, Yuji Sakuma, Eiju Tsuchiya, Yohei Miyagi, Takeshi Miura, Jinyu Sano, Yutaka Senga
Publikováno v:
Modern Pathology. 23:1492-1498
The incidence and clinical significance of the TMPRSS2:ERG gene fusion in prostate cancer has been investigated with contradictory results. It is now common knowledge that significant variability in gene alterations exists according to ethnic backgro
Autor:
Yasuhide, Miyoshi, Hiroji, Uemura, Susumu, Umemoto, Kentaro, Sakamaki, Masataka, Taguri, Kazuhiro, Suzuki, Yasuhiro, Shibata, Naoya, Masumori, Tomohiko, Ichikawa, Atsushi, Mizokami, Yoshiki, Sugimura, Norio, Nonomura, Hideki, Sakai, Seijiro, Honma, Masaoki, Harada, Yoshinobu, Kubota
Publikováno v:
The Prostate. 76(4)
There is no consensus on blood adrenal androgen concentrations in men with different stages and pathological grades of prostate cancer. In this study, dehydroepiandrosterone (DHEA) concentrations in blood were examined by ultrasensitive liquid chroma
Autor:
Yoshinobu Kubota, Masaoki Harada, Hitoshi Ishiguro, Akihide Ryo, Takeshi Sasaki, Hiroji Uemura, Yoshiaki Inayama, Shoji Yamanaka, Yoji Nagashima, Ichiro Aoki
Publikováno v:
Pathology - Research and Practice. 202:357-364
A major challenge for the management of prostate cancer (PCa) patients is to predict the clinical course of the disease after radical prostatectomy. A previous comprehensive immunohistochemical analysis using an automated image analyzer suggested tha